Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
XBI
138
HOLDINGS
24%
ALSO IN CANC
CANC
56
HOLDINGS
61%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ERASCA, INC. | 1.4% | 1.8% | 1.4% |
|
REVOLUTION MEDICINES, INC. | 1.3% | 6.1% | 1.3% |
|
COGENT BIOSCIENCES INC | 1.3% | 5.0% | 1.3% |
|
CG ONCOLOGY, INC. | 1.3% | 2.7% | 1.3% |
|
BRIDGEBIO PHARMA, INC. | 1.2% | 2.5% | 1.2% |
XBI Overweight Relative to CANC
|
APOGEE THERAPEUTICS, INC. | 1.6% |
|
ORUKA THERAPEUTICS INC | 1.4% |
|
KYMERA THERAPEUTICS, INC. | 1.4% |
|
SPYRE THERAPEUTICS INC | 1.4% |
|
DIANTHUS THERAPEUTICS INC | 1.3% |
|
TWIST BIOSCIENCE CORP. | 1.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.3% |
|
VIKING THERAPEUTICS, INC. | 1.2% |
 |
ROIVANT SCIENCES LTD. | 1.2% |
|
TRAVERE THERAPEUTICS, INC. | 1.2% |
XBI Underweight Relative to CANC
|
ELI LILLY & CO | -5.3% |
|
REVOLUTION MEDICINES, INC. | -4.8% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.5% |
|
NOVARTIS AG | -4.0% |
|
COGENT BIOSCIENCES INC | -3.8% |
|
MERCK & CO. INC. | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.5% |
|
JOHNSON & JOHNSON | -3.4% |
|
ASTRAZENECA PLC | -2.7% |
|
ABBVIE INC | -2.6% |